Lexpos News

/Lexpos News/

Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd)

Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd) Drug alert number: EL (23)A/15 Date issued: 26 April 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Beconase Hayfever Nasal Spray, PL 02855/0064 (Omega Pharma Ltd) SNOMED Code:2945411000001101 Batch No Expiry [...]

The post Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd) appeared first on PSNC Website.

By |April 26th, 2023|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd)

MP raises pharmacy closures during Prime Minister’s Questions

In today’s session of Prime Minister’s questions, Sir George Howarth MP dedicated his question to the issue of pharmacy closures and the need for Government to do more to support the sector, including commissioning a fully funded Pharmacy First service. Sir George is a strong supporter of community pharmacies and has attended several recent pharmacy-focussed [...]

The post MP raises pharmacy closures during Prime Minister’s Questions appeared first on PSNC Website.

By |April 26th, 2023|Lexpos News|Comments Off on MP raises pharmacy closures during Prime Minister’s Questions

April 2023 Price Concessions 3rd Update

The Department of Health and Social Care (DHSC) has today (25/04/2023) granted the following list of price concessions for April 2023: Drug Pack size Price concession Buprenorphine 8mg sublingual tablets sugar free 7 £4.41 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £9.23 Carbocisteine 375mg capsules 120 £7.24 Chloramphenicol 1% eye ointment 4 £5.20 Chlorpromazine [...]

The post April 2023 Price Concessions 3rd Update appeared first on PSNC Website.

By |April 25th, 2023|Lexpos News|Comments Off on April 2023 Price Concessions 3rd Update

Medicine Supply Notification: Oxybutynin 5mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/048 Tier 2 – medium impact Date of issue 24th April 2023 Oxybutynin 5mg modified-release tablets are out of stock until w/c 1st May 2023. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support [...]

The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on PSNC Website.

By |April 24th, 2023|Lexpos News|Comments Off on Medicine Supply Notification: Oxybutynin 5mg modified-release tablets

Watch out for additional copy of #SaveOurPharmacies poster

As part of the ongoing #SaveOurPharmacies campaign, further copies of the window poster are being distributed to community pharmacies in England. Following distribution of the poster in the March issue of Pharmacy Magazine, additional copies are also going out through other Communication International Group (CIG) titles. The copies will be available in the April issues [...]

The post Watch out for additional copy of #SaveOurPharmacies poster appeared first on PSNC Website.

By |April 21st, 2023|Lexpos News|Comments Off on Watch out for additional copy of #SaveOurPharmacies poster